Granulocyte colony-stimulating factor antibody abrogates radioprotective efficacy of gamma-tocotrienol, a promising radiation countermeasure

Shilpa Kulkarni, Pankaj K. Singh, Sanchita P. Ghosh, Ana Posarac, Vijay K. Singh

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

This study aimed to determine the role of granulocyte colony-stimulating factor (G-CSF), induced by a promising radiation countermeasure, gamma tocotrienol (GT3), in protecting mice from lethal doses of ionizing radiation. CD2F1 mice were injected with an optimal dose of GT3 and a G-CSF antibody, and their 30-d survival was monitored. An appropriate antibody isotype was used as a control. Multiplex Luminex was used to analyze GT3-induced cytokines. G-CSF neutralization by exogenous administration of a G-CSF antibody was confirmed by analyzing serum cytokine levels. Our results demonstrate that GT3 significantly protected mice against ionizing radiation, and induced high levels of G-CSF in peripheral blood 24. h after administration. Injection of a G-CSF neutralizing antibody to the GT3-treated mice resulted in complete neutralization of G-CSF and abrogation of its protective efficacy. Administration of a G-CSF antibody did not affect levels of other cytokines induced by GT3. Histopathology of bone marrow from GT3-treated and -irradiated mice demonstrated protection of the hematopoietic tissue, and also that such protection was abrogated by administering a G-CSF antibody. Our results suggest that induction of high levels of G-CSF by GT3 administration is responsible for its protective efficacy against radiation injury.

Original languageEnglish (US)
Pages (from-to)278-285
Number of pages8
JournalCytokine
Volume62
Issue number2
DOIs
StatePublished - May 2013
Externally publishedYes

Fingerprint

Granulocyte Colony-Stimulating Factor
Radiation
Antibodies
Ionizing radiation
Cytokines
Ionizing Radiation
plastochromanol 8
Radiation Injuries
Neutralizing Antibodies
Dosimetry
Bone
Blood
Bone Marrow
Tissue
Injections

Keywords

  • Gamma radiation
  • Gamma tocotrienol
  • Hematopoietic tissue
  • Mice
  • Radioprotection

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Hematology
  • Biochemistry
  • Molecular Biology
  • Medicine(all)

Cite this

Granulocyte colony-stimulating factor antibody abrogates radioprotective efficacy of gamma-tocotrienol, a promising radiation countermeasure. / Kulkarni, Shilpa; Singh, Pankaj K.; Ghosh, Sanchita P.; Posarac, Ana; Singh, Vijay K.

In: Cytokine, Vol. 62, No. 2, 05.2013, p. 278-285.

Research output: Contribution to journalArticle

Kulkarni, Shilpa ; Singh, Pankaj K. ; Ghosh, Sanchita P. ; Posarac, Ana ; Singh, Vijay K. / Granulocyte colony-stimulating factor antibody abrogates radioprotective efficacy of gamma-tocotrienol, a promising radiation countermeasure. In: Cytokine. 2013 ; Vol. 62, No. 2. pp. 278-285.
@article{34e2c666eb0b438cb2da6bb20bb78190,
title = "Granulocyte colony-stimulating factor antibody abrogates radioprotective efficacy of gamma-tocotrienol, a promising radiation countermeasure",
abstract = "This study aimed to determine the role of granulocyte colony-stimulating factor (G-CSF), induced by a promising radiation countermeasure, gamma tocotrienol (GT3), in protecting mice from lethal doses of ionizing radiation. CD2F1 mice were injected with an optimal dose of GT3 and a G-CSF antibody, and their 30-d survival was monitored. An appropriate antibody isotype was used as a control. Multiplex Luminex was used to analyze GT3-induced cytokines. G-CSF neutralization by exogenous administration of a G-CSF antibody was confirmed by analyzing serum cytokine levels. Our results demonstrate that GT3 significantly protected mice against ionizing radiation, and induced high levels of G-CSF in peripheral blood 24. h after administration. Injection of a G-CSF neutralizing antibody to the GT3-treated mice resulted in complete neutralization of G-CSF and abrogation of its protective efficacy. Administration of a G-CSF antibody did not affect levels of other cytokines induced by GT3. Histopathology of bone marrow from GT3-treated and -irradiated mice demonstrated protection of the hematopoietic tissue, and also that such protection was abrogated by administering a G-CSF antibody. Our results suggest that induction of high levels of G-CSF by GT3 administration is responsible for its protective efficacy against radiation injury.",
keywords = "Gamma radiation, Gamma tocotrienol, Hematopoietic tissue, Mice, Radioprotection",
author = "Shilpa Kulkarni and Singh, {Pankaj K.} and Ghosh, {Sanchita P.} and Ana Posarac and Singh, {Vijay K.}",
year = "2013",
month = "5",
doi = "10.1016/j.cyto.2013.03.009",
language = "English (US)",
volume = "62",
pages = "278--285",
journal = "Cytokine",
issn = "1043-4666",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Granulocyte colony-stimulating factor antibody abrogates radioprotective efficacy of gamma-tocotrienol, a promising radiation countermeasure

AU - Kulkarni, Shilpa

AU - Singh, Pankaj K.

AU - Ghosh, Sanchita P.

AU - Posarac, Ana

AU - Singh, Vijay K.

PY - 2013/5

Y1 - 2013/5

N2 - This study aimed to determine the role of granulocyte colony-stimulating factor (G-CSF), induced by a promising radiation countermeasure, gamma tocotrienol (GT3), in protecting mice from lethal doses of ionizing radiation. CD2F1 mice were injected with an optimal dose of GT3 and a G-CSF antibody, and their 30-d survival was monitored. An appropriate antibody isotype was used as a control. Multiplex Luminex was used to analyze GT3-induced cytokines. G-CSF neutralization by exogenous administration of a G-CSF antibody was confirmed by analyzing serum cytokine levels. Our results demonstrate that GT3 significantly protected mice against ionizing radiation, and induced high levels of G-CSF in peripheral blood 24. h after administration. Injection of a G-CSF neutralizing antibody to the GT3-treated mice resulted in complete neutralization of G-CSF and abrogation of its protective efficacy. Administration of a G-CSF antibody did not affect levels of other cytokines induced by GT3. Histopathology of bone marrow from GT3-treated and -irradiated mice demonstrated protection of the hematopoietic tissue, and also that such protection was abrogated by administering a G-CSF antibody. Our results suggest that induction of high levels of G-CSF by GT3 administration is responsible for its protective efficacy against radiation injury.

AB - This study aimed to determine the role of granulocyte colony-stimulating factor (G-CSF), induced by a promising radiation countermeasure, gamma tocotrienol (GT3), in protecting mice from lethal doses of ionizing radiation. CD2F1 mice were injected with an optimal dose of GT3 and a G-CSF antibody, and their 30-d survival was monitored. An appropriate antibody isotype was used as a control. Multiplex Luminex was used to analyze GT3-induced cytokines. G-CSF neutralization by exogenous administration of a G-CSF antibody was confirmed by analyzing serum cytokine levels. Our results demonstrate that GT3 significantly protected mice against ionizing radiation, and induced high levels of G-CSF in peripheral blood 24. h after administration. Injection of a G-CSF neutralizing antibody to the GT3-treated mice resulted in complete neutralization of G-CSF and abrogation of its protective efficacy. Administration of a G-CSF antibody did not affect levels of other cytokines induced by GT3. Histopathology of bone marrow from GT3-treated and -irradiated mice demonstrated protection of the hematopoietic tissue, and also that such protection was abrogated by administering a G-CSF antibody. Our results suggest that induction of high levels of G-CSF by GT3 administration is responsible for its protective efficacy against radiation injury.

KW - Gamma radiation

KW - Gamma tocotrienol

KW - Hematopoietic tissue

KW - Mice

KW - Radioprotection

UR - http://www.scopus.com/inward/record.url?scp=84876801589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876801589&partnerID=8YFLogxK

U2 - 10.1016/j.cyto.2013.03.009

DO - 10.1016/j.cyto.2013.03.009

M3 - Article

C2 - 23561424

AN - SCOPUS:84876801589

VL - 62

SP - 278

EP - 285

JO - Cytokine

JF - Cytokine

SN - 1043-4666

IS - 2

ER -